Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report)'s stock price shot up 8.4% on Wednesday . The stock traded as high as $9.01 and last traded at $8.77. 1,154,817 shares changed hands during trading, a decline of 41% from the average session volume of 1,970,916 shares. The stock had previously closed at $8.09.
Wall Street Analysts Forecast Growth
ASPN has been the topic of several recent research reports. Barclays downgraded shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and upped their price objective for the company from $7.00 to $16.00 in a report on Monday, August 11th. Canaccord Genuity Group lowered their price objective on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Finally, Weiss Ratings reissued a "sell (d)" rating on shares of Aspen Aerogels in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $19.50.
Get Our Latest Report on Aspen Aerogels
Aspen Aerogels Stock Performance
The company has a market capitalization of $732.59 million, a PE ratio of -2.33 and a beta of 2.80. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98. The stock's fifty day simple moving average is $7.16 and its 200-day simple moving average is $6.50.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.08. The business had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The company's revenue was down 33.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.21 EPS. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, equities analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.
Insider Buying and Selling at Aspen Aerogels
In related news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total transaction of $32,237.10. Following the completion of the sale, the chief accounting officer owned 19,879 shares of the company's stock, valued at approximately $145,315.49. This represents a 18.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.40% of the stock is currently owned by insiders.
Institutional Trading of Aspen Aerogels
A number of institutional investors and hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC grew its position in Aspen Aerogels by 1,998.7% in the first quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company's stock valued at $210,000 after acquiring an additional 3,158 shares in the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of Aspen Aerogels by 1,094.8% during the second quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company's stock valued at $28,000 after purchasing an additional 4,390 shares during the period. SBI Securities Co. Ltd. grew its holdings in Aspen Aerogels by 67.3% during the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company's stock worth $38,000 after acquiring an additional 2,551 shares during the period. Acadian Asset Management LLC acquired a new position in Aspen Aerogels during the first quarter worth about $43,000. Finally, Banque Cantonale Vaudoise acquired a new position in Aspen Aerogels during the first quarter worth about $45,000. Institutional investors and hedge funds own 97.64% of the company's stock.
Aspen Aerogels Company Profile
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.